Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India

NCT00923702 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

22729

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Cervical Precancerous Lesions

Interventions

BIOLOGICAL: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®)

Sponsor

Partha Basu

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]